Regulation of human prostasin-like serine protease
US7049420B2 · kind B2 · utility
2Cited by
0References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 22, 2001 |
| Grant date | May 23, 2006 |
| Priority date | — |
| Expiry date | May 1, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Reagents which regulate human prostasin-like enzyme activity and reagents which bind to human prostasin-like enzyme gene products can be used to regulate human prostasin-like enzyme activity. Such regulation is particularly useful for treating metastasis of malignant cells, tumor angiogenesis, inflammation, atherosclerosis, neurodegenerative diseases, and pathogenic infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.